Heart valve disease presenting in adults: investigation and management

on anticoagulation and antiplatelet therapy. Full details of the evidence and the committee's discussion are in evidence review J: anticoagulant and/or antiplatelet therapy for biological prosthetic valves and after valve repair. 1.8 Monitoring after an intervention 1.8.1 Base decisions on the frequency and type of monitoring for adults who have had an intervention (valve repair or replacement) for valve disease on: • durability of the prosthetic valve or durability of the repair • the presence of another condition, including other heart disease • residual valve abnormality or consequences of the procedure, for example, paravalvular leak • concerns about abnormal function of the prosthetic valve • the patient's wishes. Advise people and their family members or carers (as appropriate) to seek advice if the heart condition deteriorates. For a short explanation of why the committee made this recommendation and how it might affect practice, see the rationale and impact section on monitoring after an intervention. Full details of the evidence and the committee's discussion are in evidence review K: monitoring in people with repaired or replaced heart valves. 1.9 Information and advice 1.9.1 Follow the NICE guideline on shared decision making and the recommendations in the NICE guideline on patient experience
